Quinolinyl-pyrrolopyrazoles
A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Beight, Douglas Wade Sawyer, Jason Scott Yingling, Jonathan Michael |
| description | A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07265225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07265225</sourcerecordid><originalsourceid>FETCH-uspatents_grants_072652253</originalsourceid><addsrcrecordid>eNrjZJAOLM3My8_JzKvM0S2oLCrKz8kHUolV-TmpxTwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZmBuZmRoZmRoToQQAv5IlSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinolinyl-pyrrolopyrazoles</title><source>USPTO Issued Patents</source><creator>Beight, Douglas Wade ; Sawyer, Jason Scott ; Yingling, Jonathan Michael</creator><creatorcontrib>Beight, Douglas Wade ; Sawyer, Jason Scott ; Yingling, Jonathan Michael ; Eli Lilly and Company</creatorcontrib><description>A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.</description><language>eng</language><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7265225$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7265225$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Beight, Douglas Wade</creatorcontrib><creatorcontrib>Sawyer, Jason Scott</creatorcontrib><creatorcontrib>Yingling, Jonathan Michael</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Quinolinyl-pyrrolopyrazoles</title><description>A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJAOLM3My8_JzKvM0S2oLCrKz8kHUolV-TmpxTwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZmBuZmRoZmRoToQQAv5IlSw</recordid><startdate>20070904</startdate><enddate>20070904</enddate><creator>Beight, Douglas Wade</creator><creator>Sawyer, Jason Scott</creator><creator>Yingling, Jonathan Michael</creator><scope>EFH</scope></search><sort><creationdate>20070904</creationdate><title>Quinolinyl-pyrrolopyrazoles</title><author>Beight, Douglas Wade ; Sawyer, Jason Scott ; Yingling, Jonathan Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_072652253</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Beight, Douglas Wade</creatorcontrib><creatorcontrib>Sawyer, Jason Scott</creatorcontrib><creatorcontrib>Yingling, Jonathan Michael</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Beight, Douglas Wade</au><au>Sawyer, Jason Scott</au><au>Yingling, Jonathan Michael</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinolinyl-pyrrolopyrazoles</title><date>2007-09-04</date><risdate>2007</risdate><abstract>A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07265225 |
| source | USPTO Issued Patents |
| title | Quinolinyl-pyrrolopyrazoles |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Beight,%20Douglas%20Wade&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2007-09-04&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07265225%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |